| | Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamoylanthranilic Acid)CAS:3086-91-7 |
|
| | Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)CAS:81886-51-3 |
|
| | Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropylamine)CAS:23580-89-4 |
|
| | Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester)CAS:129332-29-2 |
|
| | Gadoteridol Related Compound A (50 mg) (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)CAS:120041-08-9 |
|
| | Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid)CAS:220182-19-4 |
|
| | Gadoteridol Related Compound B (50 mg) (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt)CAS:112188-16-6 |
|
| | 加巴喷丁杂质BCAS:133481-09-1 |
|
| | 加巴喷丁杂质ACAS:64744-50-9 |
|
| | 格列美脲杂质C(格列美脲氨基甲酸乙酯)CAS:119018-30-3 |
|
| | Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS)CAS:21165-77-5 |
|
| | Haloperidol Related Compound A (10 mg) (4,4'-Bis[4-(pchlorophenyl)-4-hydroxy-piperidino]-butyrophenone)CAS:67987-08-0 |
|
| | Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate)CAS:537-29-1 |
|
| | Ioxilan Related Compound A (100 mg) (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid)CAS:22871-58-5 |
|
| | Ioversol Related Compound A (50 mg) (5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)CAS:76801-93-9 |
|
